AbbVie, Johnson & Johnson Lead US Immunology Drug Market Due to High Cost of Biologic Treatments
According to a new exciting and unprecedented 1000+ page report series on the U.S. market for immunology drugs by iData Research (www.idataresearch.com), the immunology market is facing strong competition and cost pressure from new entrants, which limits the commercial potential of these drugs. Another concern is the significant unmet needs to treat relevant diseases, in terms of safer treatments and more convenient administration.
View full press release